Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

A Patient with Repeated Catastrophic Multi-Vessel Coronary Spasm after Zotarolimus-Eluting Stent Implantation

  • Rhew, Shi Hyun (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Ahn, Youngkeun (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Cho, Eun Ae (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Kim, Min Sok (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Jang, Su Young (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Lee, Ki Hong (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Lee, Min Goo (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Park, Keun Ho (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Sim, Doo Sun (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Hong, Young Joon (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Kim, Ju Han (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital) ;
  • Jeong, Myung Ho (Department of Cardiology, Cardiovascular Center, Chonnam National University Hospital)
  • Published : 2013.01.30
⟨ Previous Next ⟩

Abstract

Drug-eluting stents (DES) have gained great popularity because of extraordinarily low rates of restenosis. Despite these superior clinical outcomes, several cases regarding the severe multi-vessel coronary spasm, although rare, after the placement of first generation DES have been reported. We report a case of severe, multi-vessel coronary spasm that occurred two occasions after placement of a zotarolimus-eluting stent, one of the second generation DES, in a 42-year-old man with unstable angina. The first incidence was relieved by intracoronary nitroglycerin alone, and second incident, which had combined fixed stenosis was treated with intracoronary nitroglycerin and everolimus-eluting stent.

Keywords

References

  1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80. https://doi.org/10.1056/NEJMoa012843
  2. Kounis NG, Kounis GN, Soufras GD. Kounis syndrome: a potential cause of simultaneous multivessel coronary spasm and thrombosis after drug-eluting stent implantation. J Invasive Cardiol 2007;19:200-1.
  3. Tomassini F, Varbella F, Gagnor A, Infantino V, Luceri S, Conte MR. Severe multivessel coronary spasm after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown) 2009;10:485-8. https://doi.org/10.2459/JCM.0b013e32831daf84
  4. Brott BC, Anayiotos AS, Chapman GD, Anderson PG, Hillegass WB. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 2006;18:584-92.
  5. Togni M, Eberli FR. Vasoconstriction and coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 2006;18:593.
  6. Kim JW, Park CG, Seo HS, Oh DJ. Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation. Heart 2005; 91:e15. https://doi.org/10.1136/hrt.2004.049932
  7. Butt M, Connolly D, Lip GY. Drug-eluting stents: a comprehensive appraisal. Future Cardiol 2009;5:141-57. https://doi.org/10.2217/14796678.5.2.141
  8. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46:231-6. https://doi.org/10.1016/j.jacc.2005.01.062
  9. Tan W, Cheng KL, Chen QX. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome? Chin Med J (Engl) 2009;122:2390-3.
  10. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-93. https://doi.org/10.1161/hc3601.093987
  11. Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 2009;57:567-84.
  12. Koh KK, Moon TH, Song JH, et al. Comparison of clinical and laboratory findings between patients with diffuse three-vessel coronary artery spasm and other types of coronary artery spasm. Cathet Cardiovasc Diagn 1996;37:132-9. https://doi.org/10.1002/(SICI)1097-0304(199602)37:2<132::AID-CCD6>3.0.CO;2-E
  13. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9. https://doi.org/10.1161/01.CIR.87.1.76
  14. Park YM, Han SH, Ko KP, et al. Diffuse multi-vessel coronary artery spasm: incidence and clinical prognosis. Int J Cardiol 2012 [Epub ahead of print].
  15. Chuang YT, Ueng KC. Spontaneous and simultaneous multivessel coronary spasm causing multisite myocardial infarction, cardiogenic shock, atrioventricular block, and ventricular fibrillation. Circ J 2009;73: 1961-4. https://doi.org/10.1253/circj.CJ-08-0589
  16. Kusama Y, Kodani E, Nakagomi A, et al. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management. J Nihon Med Sch 2011;78:4-12. https://doi.org/10.1272/jnms.78.4
  17. Miyagi H, Yasue H, Okumura K, Ogawa H, Goto K, Oshima S. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation 1989;79:597-602. https://doi.org/10.1161/01.CIR.79.3.597
  18. Teragawa H, Kato M, Yamagata T, Matsuura H, Kajiyama G. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 2000;118:1690-5. https://doi.org/10.1378/chest.118.6.1690
  19. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32:1672-9. https://doi.org/10.1016/S0735-1097(98)00447-1
  20. Yasue H, Mizuno Y, Harada E, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51:1742-8. https://doi.org/10.1016/j.jacc.2007.12.049
  21. Park YM, Kang WC, Shin KC, et al. Repeated sudden cardiac death in coronary spasm: is IVUS helpful to decide treatment strategy? Int J Cardiol 2012;154:e57-9. https://doi.org/10.1016/j.ijcard.2011.06.034
  22. Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173-8. https://doi.org/10.1016/j.ijcard.2007.12.022
  23. Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-81. https://doi.org/10.1016/j.jacc.2005.07.071
  24. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52:333-42. https://doi.org/10.1016/j.jacc.2008.04.030
  25. Sarno G, Lagerqvist B, Carlsson J, et al. Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Int J Cardiol 2012 [Epub ahead of print].

Cited by

  1. Zotarolimus : Multi-vessel coronary spasm: case report vol.1446, pp.1, 2013, https://doi.org/10.1007/s40278-013-2360-2
  2. Coronary vasomotion dysfunction after everolimus-eluting stent implantation vol.6, pp.4, 2013, https://doi.org/10.1556/imas.6.2014.4.6
  3. Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature vol.7, pp.4, 2016, https://doi.org/10.7150/jca.13611